Homepage | Home | Bookmarke
Member

Liaoning Boao Biological Pharmaceutical Co.,ltd


Products
  • No Category
Search
 

Friends links
  • No link
You are here: Home » Products » A New Generation Of Meglitinide Oral Hypoglycemic Agents
A New Generation Of Meglitinide Oral Hypoglycemic Agents
Click image to view full size image
Product: Views:223A New Generation Of Meglitinide Oral Hypoglycemic Agents 
Unit price: Negotiable
MOQ:
Quantity:
Delivery date: Since the payment date Days delivery
Valid until: Long-term effective
Last updated: 2017-12-22 02:55
  Inquiry
Details

A new generation of meglitinide oral hypoglycemic agents----Mitiglinide Calcium Tablets 

Specification:5mg*15pieces*2

Oral Hypoglycemic DrugsPatients can take it orally.

Indications:

Improve postprandial hyperglycemia in patients with type 2 diabetes (only for diabetics, exercise therapy can not effectively control blood glucose in patients with diet, exercise therapy based on the addition of α-glucosidase inhibitors can not effectively control the blood sugar patient).

Dosage:

5 minutes before the meal orally. Usually adult 10mg (2 tablets), 3 times a day. According to the patient's treatment effect, as appropriate, adjust the dose.


Inquiry